March 25, 2021
“Oncolytics Biotech (ONCY)… Turning now to the rest of the Street, other analysts are on the same page. With 5 Buys and no Holds or Sells, the word on the Street is that ONCY is a Strong Buy. Given its… Continue Reading…
March 23, 2021
“Nuance Communications (NUAN)… Ives is no outlier on Nuance, as shown by the unanimous Strong Buy analyst consensus on the stock. Nuance has received 6 recent reviews, and all are to Buy. The shares are trading for $45.20, and the $59.67… Continue Reading…
March 9, 2021
“iCAD, Inc. (ICAD)… The unanimous Strong Buy consensus rating on ICAD shares shows that Wall Street is in broad agreement with Oppenheimer’s analyst; there are 7 Buy-side ratings on ICAD shares. The $21.57 average price target implies an upside of 30%… Continue Reading…
February 24, 2021
“Avalara, Inc. (AVLR)… Of the 11 analysts who have reviewed Avalara in recent weeks, 10 agree with Bracelin that this is a stock to buy, and this breakdown of 10 Buys to 1 Hold gives the company a Strong Buy analyst… Continue Reading…
February 23, 2021
“Linde PLC (LIN)… Wall Street’s analysts are in broad agreement on the quality of Linde’s stock, as shown by the 15 Buy reviews overbalancing the 3 Holds. This gives the stock its Strong Buy analyst consensus rating. Shares are priced at… Continue Reading…
February 17, 2021
“Williams Companies (WMB)… With 8 recent reviews on record, including 7 Buys and just 1 Hold, WMB has earned its Strong Buy analyst consensus rating. While the stock has gained in recent months, reaching $23, the average price target of… Continue Reading…
February 11, 2021
“Village Farms International (VFF)… Overall, there are 3 recent reviews on VFF shares, and all are Buys, giving the stock a Strong Buy analyst consensus rating and showing a general agreement on Wall Street about the company’s strengths. Shares are… Continue Reading…
January 22, 2021
“Facebook (FB)… Overall, the social media empire remains a Wall Street darling, as TipRanks analytics showcasing FB as a Strong Buy. This is based on 34 recent reviews, which break down to 30 Buy ratings, 3 Holds, and 1 Sell. Shares… Continue Reading…
January 21, 2021
“AzurRx BioPharma (AZRX)… Overall, the analyst consensus on AZRX shares is a Strong Buy; the stock has 4 recent reviews, including 3 Buys and a single Hold. In addition, the $4 average price target brings the upside potential to 304%…… Continue Reading…
January 18, 2021
“Talos Energy (TALO)… Overall, with five analyst reviews on file, including 4 Buys and a single Hold, Talos gets a Strong Buy rating from the analyst consensus. Shares are priced at $9.96, and their $14.33 average target gives ~44% upside… Continue Reading…
Recent Comments